The trial of Elizabeth Holmes resulted in a mixed verdict, but one outcome is clear: This was a big victory for prosecutors in a high-profile case where the defendant now faces a lengthy prison sentence.
Holmes’ conviction on four fraud charges involving huge sums of money invested in Theranos, the now-shuttered blood testing startup with Holmes at the helm, means she will likely spend many years behind bars. The three wire fraud counts accounted for more than $144 million in investments, a sum that will significantly drive up the length of her sentence, legal experts said.
“She was convicted on the big counts,” said Erik Gordon, a business and law professor at the University of Michigan. “The big counts were the fraud committed against investors, not the counts involving the patients.”
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
